Position in ABBV
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$673,388
+$113,352 QoQ
Shares Held
2,676
+3.9% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.58%
of 13F equity value
Holder Rank
#2,907
of 4,153 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Severin Investments, LLC holds $6,087,286 across 8 Drug Manufacturers - General names. ABBV ranks #4 (11.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
|
10,464 | $1,344,624 | |
| 2 | JNJ |
Johnson & Johnson
|
4,781 | $1,214,230 | |
| 3 | LLY |
ELI LILLY & Co
|
926 | $1,110,672 | |
| 4 | ABBV |
AbbVie Inc.
This page
|
2,676 | $673,388 | |
| 5 | NVS |
Novartis AG
|
3,333 | $522,347 | |
| 6 | AMGN |
Amgen Inc
|
1,158 | $419,334 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
7,029 | $405,010 | |
| 8 | PFE |
Pfizer Inc
|
16,515 | $397,681 |
All Filings in ABBV
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $673,388 | 2,676 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $560,036 | 2,575 | Shares | Sole | 2026-04-24 | |
| 2025-12-31 | $566,883 | 2,481 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $881,009 | 3,805 | Shares | Sole | 2025-12-03 | |
| 2025-06-30 | $1,121,887 | 6,044 | Shares | Sole | 2025-12-03 | |
| 2025-03-31 | $1,309,500 | 6,250 | Shares | Sole | 2025-12-03 | |
| 2024-12-31 | $1,087,524 | 6,120 | Shares | Sole | 2025-12-03 | |
| No filing history on record for this holder in this stock. | ||||||